Gene · 6046
Papers3,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma. | J Transl Med | 2025 | 40011918 | PubTator, text mining | PubMed |
| Relative quantification of proteins and post-translational modifications in proteomic experiments with shared peptides: a weight-based approach. | Bioinformatics | 2025 | 39888862 | PubTator, text mining | PubMed |
| Correction to "Development of BromoTag: A "Bump-and-Hole"-PROTAC System To Induce Potent, Rapid, and Selective Degradation of Tagged Target Proteins". | J Med Chem | 2025 | 39838864 | PubTator, text mining | PubMed |
| Activation of the 26S Proteasome to Reduce Proteotoxic Stress and Improve the Efficacy of PROTACs. | ACS Pharmacol Transl Sci | 2025 | 39816802 | PubTator, text mining | PubMed |
| Helicobacter Pylori-induced BRD2 m6A modification sensitizes gastric cancer cells to chemotherapy by breaking FLIP/Caspase-8 homeostasis. | Int J Biol Sci | 2025 | 39744419 | PubTator, text mining | PubMed |
| Covalent Proximity Inducers. | Chem Rev | 2025 | 39692621 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| Histone Modifications in the Anoxic Northern Crayfish, Faxonius virilis. | Mar Biotechnol (NY) | 2024 | 39576345 | PubTator, text mining | PubMed |
| Targeted protein degradation: advances in drug discovery and clinical practice. | Signal Transduct Target Ther | 2024 | 39500878 | PubTator, text mining | PubMed |
| Association between maternal perinatal stress and depression and infant DNA methylation in the first year of life. | Transl Psychiatry | 2024 | 39438450 | PubTator, text mining | PubMed |
| RNA kinetics influence the response to transcriptional perturbation in leukaemia cell lines. | NAR Cancer | 2024 | 39372038 | PubTator, text mining | PubMed |
| Enhanced 2D Hand Pose Estimation for Gloved Medical Applications: A Preliminary Model. | Sensors (Basel) | 2024 | 39338750 | PubTator, text mining | PubMed |
| Transcriptional control of interferon-stimulated genes. | J Biol Chem | 2024 | 39276937 | PubTator, text mining | PubMed |
| Unraveling the Role of Bromodomain and Extra-Terminal Proteins in Human Uterine Leiomyosarcoma. | Cells | 2024 | 39273015 | PubTator, text mining | PubMed |
| Short communication: An alternative pathway for melatonin synthesis in the skin of European flounder (Platichthys flesus). | Comp Biochem Physiol A Mol Integr Physiol | 2024 | 39187010 | PubTator, text mining | PubMed |
| Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities. | Gut Microbes | 2024 | 39150897 | PubTator, text mining | PubMed |
| SARS-CoV-2 E protein interacts with BRD2 and BRD4 SEED domains and alters transcription in a different way than BET inhibition. | Cell Mol Life Sci | 2024 | 39066826 | PubTator, text mining | PubMed |
| Mitochondrial Control of Proteasomal Psmb5 Drives the Differentiation of Tissue-Resident Memory T Cells in Patients with Rheumatoid Arthritis. | Arthritis Rheumatol | 2024 | 39037181 | PubTator, text mining | PubMed |
| YEATS domain-containing protein GAS41 regulates nuclear shape by working in concert with BRD2 and the mediator complex in colorectal cancer. | Pharmacol Res | 2024 | 38964523 | PubTator, text mining | PubMed |
| Therapeutic targets for age-related macular degeneration: proteome-wide Mendelian randomization and colocalization analyses. | Front Neurol | 2024 | 38903171 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6046/papers?page=6